Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension

Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension

Abstract Aims Right ventricular dysfunction may arise because of pulmonary arterial hypertension (PAH). Development of new diagnostic methods able to identify PAH and allow for earlier treatment initiation, before the development of vascular remodelling and manifest right heart failure (HF), could p...

Full description

Bibliographic Details
Main Authors: Mattias Arvidsson, Abdulla Ahmed, Habib Bouzina, Göran Rådegran
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:ESC Heart Failure
Subjects:
Differentiation
Plasma biomarkers
Prolargin
Proteoglycans
Pulmonary hypertension
Online Access:https://doi.org/10.1002/ehf2.13184

Internet

https://doi.org/10.1002/ehf2.13184

Similar Items